Remarkably, in four types of carcinomas (breast, ovary, liver, and lung carcinomas) arising from normal counterparts co-expressing ERAP1 and ERAP2, none of the 26 tested samples retained this phenotype. Here, ERAP2 is linked to lung carcinoma.